Objectives: to determine the incidence of post-operative troponin I rises and its association with 1-year all-cause mortality and cardiac events after emergency orthopaedic-geriatric surgery, which has not been studied before. Methods: one hundred and two patients over the age of 60 were recruited and followed up at 1 year. All consented to serial troponin I measurements peri-operatively. Results: the incidence of a troponin I rise post-operatively was 52.9%. Post-operative acute myocardial infarction was diagnosed in 9.8% and at 1 year, 70% of these patients were dead. At 1 year, 32.4% (33/102) had sustained a cardiac event (myocardial infarction, congestive cardiac failure, atrial fibrillation or major arrhythmia) and using multivariate analysis, postoperative troponin rise (OR 3.9, 95% CI 1.4-10.7, P = 0.008) was an independent predictor of this. Half of the patients with a troponin rise had a cardiac event compared to 18.8% without a rise. All-cause mortality was 20.6% at 1 year; 37% with an associated post-operative troponin rise died versus 2.1% without a rise (P < 0.0001). Using multivariate analysis, only two factors were associated with 1-year all-cause mortality: post-operative troponin rise (OR 12.0, 95% CI 1.4-104.8, P = 0.025) and sustaining a post-operative in-hospital cardiac event (OR 6.6, 95% CI 1.7-25.6, P = 0.006). Furthermore, patients with higher troponin levels had significantly worse survival. Conclusions: there is a high incidence of post-operative troponin I rises in older patients undergoing emergency orthopaedic surgery with 1-year mortality and cardiac events being significantly increased in these patients. Future studies are needed to determine whether any intervention can improve outcome for these patients.
Introduction
Post-operative cardiac ischaemic injury is a significant concern in older patients undergoing non-cardiac surgery. It is often undiagnosed and under-recognised and recently this topic has received more attention [1] . Troponin has emerged as the biomarker of choice for the detection of myocardial injury, being a more sensitive and specific marker compared to CK and CK-MB [2] [3] [4] [5] . To diagnose myocardial infarction, recent guidelines emphasise the detection of a rise in cardiac biomarkers (preferably troponin) with at least one measurement above the 99th percentile of the upper reference limit, together with evidence of myocardial ischaemia (either symptoms, ECG changes or imaging such as echocardiography) [6] . However, the diagnosis of myocardial infarction is challenging during the post-operative period. First, ECG changes are not always present and can be difficult to interpret when there are background abnormalities [7] . Secondly, analgesics and hypnotics may blunt cardiac pain perception and cognitively impaired patients may not be able to effectively communicate their symptoms [8] . Therefore, there may be more reliance on biochemical markers during the post-operative period but there are no established cut-offs given the difficulties in diagnosis during this time [9] .
There are few studies investigating the incidence of troponin rises and long-term outcomes after orthopaedic surgery Troponin I rises and emergency orthopaedic surgery [4, 10, 11] . In fact, none focus solely on an emergency geriatric cohort. Therefore, the objective was to determine the incidence of post-operative troponin I elevations and 1-year all-cause mortality rates and cardiac events in an emergency orthopaedic-geriatric population.
Methods

Study population
This prospective study was conducted in a metropolitan teaching hospital (The Northern Hospital, Epping Victoria) and approved by the hospital's human research and ethics committee. The inclusion criteria were limited to patients over the age of 60 who were admitted under the orthopaedic unit and underwent emergency orthopaedic surgery. Emergency surgery was defined as non-elective surgery mainly for trauma (e.g. fractures) or an acute condition such as septic arthritis. Consequently, types of surgeries performed included open reduction and internal fixation, hemiarthroplasties, general anaesthetic and manipulation of plaster and joint washouts. Patients were excluded if they did not undergo emergency surgery, died before surgery or were initially admitted under a different unit. Eligible patients were recruited between April 2006 and December 2006 and provided written consent. All patients underwent standard hospital management and investigations during their admission.
Cardiac troponin I
Serum for troponin I measurement was taken from blood samples already stored in the laboratory for tests ordered by the treating clinical unit as part of standard care; therefore, no extra blood was taken from the patients. For each subject, serums identified as taken pre-operatively and on days 1, 2 and 3 post-operatively were aliquoted and stored at −70
• C. This time frame was chosen as most cardiac events occur within 3 days of an operation [12, 13] . If a patient had less than three post-operative blood samples, then additional troponin I measurements were performed between days 4 and 7 where a specimen was available. Thus, a maximum of four troponin measurements were performed on any one patient. Before frozen storage, all serum samples were handled in a standard manner with storage at 4
• C for up to 7 days. The troponin assay maintained stability over this time with repeat testing of representative samples over this period.
Troponin I was assayed at least 30 days after collection so that patients would receive usual care during the postoperative period. The treating orthopaedic-geriatric unit was blinded to these results. However, where the treating unit clinically suspected a cardiac event, routine protocols for investigation and management were followed. The diagnosis of acute myocardial infarction was made by the treating unit using standard criteria [6] . If a troponin was requested by the treating unit on a sample that was eligible for analysis in the study, then this result was used instead of re-analysing the same sample.
Prior to analysis, the frozen serum was thawed, thoroughly mixed and re-centrifuged. Serum was analysed for troponin I at a mean of 46 days (range 30-86) after the sample was collected. Troponin I was measured using the Architect STAT Troponin I assay (Abbott Diagnostics). The 99th percentile of a healthy reference population using this assay has been previously established at 0.03 mcg/l and levels above this are considered indicative of myocardial injury. The coefficient of variation (CV) for this assay has previously been shown to be 10% near the 99th percentile [2] . Clinical guidelines have specified the use of the 99th percentile as the reference cutoff in assays demonstrating 10% CV at this level. Recently, emphasis has been placed on the use of the 99th percentile level regardless of total imprecision at this level. A number of our samples were validated in our laboratory and repeatedly checked over time and all were within the CV at that level of troponin.
As part of standard hospital care, all patients had preoperative ECGs. Any post-operative ECGs ordered by the treating unit were included in the study but no additional ECGs were requested. ECGs were interpreted by the investigators only. Demographic and medical data relating to each patient were obtained by a physician reviewing their medical histories. Cardiac events were determined by documentation in the medical records by the treating unit. A 1-year follow-up was performed using a semi-structured telephone interview with either the patient or their carer and by viewing the medical records. The patient's general practitioner was also contacted for more information if necessary.
Statistical analysis
A comprehensive statistical analysis was performed using the SPSS (version 12) statistical program and Excel 2003 (version 11). Risk factors were evaluated using binary logistical regression to determine the odds ratio and probabilities of each variable then multiple logistical regression was undertaken for the primary dependent variable (e.g. troponin). All variables with a P-value < 0.05 in the univariate analysis were then candidate in the multivariate analysis using stepwise logistic regression, testing a maximum of five factors per model to ensure stability. Estimated odds ratios and 95% confidence intervals with probability values are reported. Linear regression was used for continuous variables. KaplanMeier curves were constructed to examine survival time after orthopaedic surgery. Survival at 1 year between patients with an elevated troponin and also between different troponin ranges was compared by means of a log-rank test.
Results
A total of 119 consecutive patients were invited to participate in the study. Seventeen were excluded (two did not have surgery, seven consented but blood was not stored in time, one died pre-operatively, two decided to withdraw and five declined participation) leaving a total of 102 patients in the study. Two patients out of 102 were lost to the follow-up at 1 year. The mean age was 79 years (standard deviation of 10 years) and 73% were women. Most patients came from home (85%) versus 15% from residential care. Table 1 shows the characteristics of the subjects.
Incidence of a post-operative troponin rise
The incidence of a post-operative troponin rise was 52.9% (54/102 patients). When pre-operative troponin elevations were also included without post-operative rise, the incidence of an elevated troponin peri-operatively was 61.8% (63/102). The mean time to peak troponin rise was 2 days postoperatively (range 1-4 days). The majority (72.2%) of those with a post-operative rise had troponin measurements on three consecutive post-operative days 1-3. Fifteen of fifty-four patients (27.8%) had post-operative blood tested between days 1 and 5. Overall, most patients (78/102 or 76.5%) had three post-operative blood samples tested for troponin I. 17.6% had only two post-operative samples and 5.9% only had a single suitable post-operative sample which was compared to the pre-operative sample.
One-year mortality
At 1 year, 20.6% (21/102) of the cohort died. The most striking finding however was a strong association between raised troponin levels and 1-year mortality. Twenty patients with an associated post-operative troponin rise died (20/54 or 37.0%) versus one patient (1/48 or 2.1%) with a normal troponin level. A Kaplan-Meier survival curve of all-cause mortality at 1 year (Figure 1a) showed a significant difference (P < 0.0001) between these two groups. For patients who had a troponin rise, 50% died of a cardiovascular cause. Two factors were associated with all-cause mortality during the first post-operative year using multivariate analysis: post-operative troponin rise (OR 12.0, 95% CI 1.4-104.8, P = 0.025) and sustaining a post-operative cardiac event (OR 6.6, 95% CI 1.7-25.6, P = 0.006) (see Table 2 ). A second Kaplan-Meier survival curve was constructed dividing patients according to their highest post-operative or peak troponin level (Figure 1b) . Patients with higher troponin levels had significantly worse survival at 1 year. The 1-year mortality according to peak troponin levels was 2.1% (1/48 patients) for troponin levels ≤0.03 mcg/l, 23.1% (6/26) between 0.04 and 0.1 mcg/l, 42.9% (6/14) between >0.1 and 0.3 mcg/l and 57.1% (8/14) if >0.3 mcg/l.
Predictors of a troponin rise
Univariate analysis was performed to determine factors that contributed to a troponin rise (see Table 1 ). These variables were used in a binary logistic regression model, with the dependent variable being troponin rise above 0.03 mcg/l. Using multiple logistic regression, only two factors were predictive of a troponin rise; receiving a post-operative blood transfusion (OR 8.5; 95% CI 2.3-31.5, P = 0.001) and premorbid ischaemic heart disease (OR 4.5; 95% CI 1.5-14.1, P = 0.009) when adjusted for age, premorbid congestive cardiac failure and premorbid renal failure.
In-hospital, post-operative cardiac events
The percentage of in-hospital cardiac events was 25.5% (26/102 patients). A total of 40.7% (22/54) of patients with a troponin rise sustained a cardiac event compared to 8.3% (4/48) without a rise. Therefore, the majority of troponin rises were asymptomatic. Cardiac events included acute myocardial infarction, congestive cardiac failure, atrial fibrillation (new onset or destabilisation of pre-existing atrial fibrillation) or major arrhythmia. Clinical events were clinically determined and documented by the treating unit. Elevated troponin levels were associated with post-operative acute myocardial ischaemia (unadjusted OR 10.7; 95% CI 1.3-86.9, P = 0.027). 9.8% (10/102) of patients had an acute myocardial infarction as diagnosed by the treating unit using ECG and cardiac enzyme criteria. Therefore, 18.5% (10/54) of patients with a troponin rise were diagnosed with an acute myocardial infarction. Four ECGs showed new ST segment depression, two had old left bundle branch block, two had old ischaemic changes seen on the pre-operative ECG and two had no acute ischaemic abnormalities. All patients received routine inpatient medical treatment but none received invasive coronary intervention during this period. The inpatient mortality for these patients was 20% (two out of ten patients).
Of the remaining eight patients during the first year of the follow-up, one went on to have percutaneous coronary intervention and then coronary bypass, four died from a cardiac cause and one died of an ischaemic leg. Thus, 70% of patients who had an in-hospital acute myocardial infarction were dead at 1 year.
In-patient mortality
There were only three inpatient deaths and all had a troponin rise (with peak troponins of 0.04, 0.31, 0.83 mcg/l), the highest two troponins were diagnosed with an acute myocardial infarction. The patients died on days 12, 49 and 53. Overall, inpatient mortality rate for this study was 3.0%, and 30-day mortality was 1%. Two patients with a fractured neck of femur died and one patient had an infected total knee replacement. These patients died from (i) fat embolism, (ii) a combination of myocardial infarction, heart failure, pneumonia and sepsis and (iii) overwhelming sepsis. 
Discussion
We exclusively studied an older emergency geriatric population undergoing emergency orthopaedic surgery and found that post-operative troponin I rises are independently and significantly associated with increased mortality and increased cardiac events at 1 year. To our knowledge this has not been reported before. Our study found that patients with a troponin rise above the 99th percentile of the healthy reference range (troponin >0.03 mcg/l) were 12 times more likely to have died at 1 year compared with patients without a rise. There was also a significant relationship between the magnitude of peak troponin and 1-year mortality which is similar to previous non-cardiac and mainly vascular postoperative studies [7, [14] [15] [16] [17] . Interestingly, a recent study of 88 patients who underwent mainly scheduled (elective) hip surgery also found an association between post-operatively raised troponin levels and 1-year mortality and cardiac events [11] . Orthopaedic patients with raised troponins therefore deserve our attention due to increased mortality and cardiac events. The majority of troponin rises in this study were asymptomatic in nature. In fact, the clinical care of these patients were unchanged because the treating unit was unaware of the troponin results. However, this population of patients may benefit from early intervention and treatment. Interventions that prevent post-operative troponin rises or limit the extent of the rise are needed aiming to reduce mortality and cardiac morbidity. Strategies that have been employed mainly in vascular patients include the use of peri-operative β-blockers, statins and coronary revascularization [8] . Additionally, the follow-up of patients sustaining a post-operative troponin rise may be useful with a view to evaluating for coronary artery disease and consideration of early cardiological treatment.
Whilst our study did not specifically look at causes of post-operative troponin elevations, we found that troponin rises were associated with a wide range of co-morbid conditions. Troponin rises may not necessarily be directly due to cardiovascular disease particularly because most elevations were asymptomatic. For example, raised post-operative troponin levels may identify patients who are sicker and frailer and may be an indirect marker of general ill health. In fact, the presence of troponins in serum at concentrations above the upper reference limit indicates myocardial injury, but cannot contribute to the aetiology of the mechanism of that injury [17] . Although other surgical series have found that perioperative myocardial infarction is an important cause of a troponin rise [7, 18, 19] alternative mechanisms need to be considered such as cardiac failure, atrial fibrillation, tachycardia, pulmonary embolism, renal failure, severe sepsis and critical illness [3, [20] [21] [22] .
In this study, the inpatient mortality rate for those diagnosed with a myocardial infarction was 20% (2/10) with 70% 1-year mortality which is similar to other non-orthopaedic studies [1, 7, 9, 23] . However, the overall in-hospital mortality rate in this study was lower than other studies [24, 25] and may be due to the co-management of patients by an orthopaedic and geriatric unit and has been evaluated elsewhere [26] . Patients may benefit from orthopaedic-geriatric co-management as medical problems can be managed as they arise by a geriatrician [26] . Also, prevention of complications is important. For instance, the use of low molecular weight heparin to prevent deep venous thrombosis was routinely used by the clinicians.
There was a much higher incidence (52.9%) of postoperative troponin rises compared to the few mainly elective orthopaedic series which has ranged between 5 and 29% [4, 10, 11, 27] . We used a highly sensitive troponin assay which may explain this difference. However, our higher incidence may also reflect the older population of patients studied and the emergency nature of surgery which carries a higher risk of major peri-operative events compared with elective surgery [1, 28] .
Limitations of this study include a relatively small cohort of patients. Also, ECGs were not routinely performed post-operatively mainly because we did not want to change the usual post-operative course. It would have been interesting to know the correlation between troponin rises and ECG changes in asymptomatic patients. Additionally, not all patients had three post-operative blood samples of troponin I that could be tested but this represented the minority of patients. Therefore, we may have underestimated the incidence of troponin rises. Conversely, we feel that the major strength of this study is identifying 1-year mortality and cardiac outcomes in a unique population.
In conclusion we found that post-operative troponin rises are a prognostic marker at 1 year for death and cardiac events in an older emergency orthopaedic population. Further research is needed to see whether prevention or treatment of troponin rises can improve outcome.
Key points
r There is a high incidence of post-operative troponin I rises (52.9%) after emergency orthopaedic surgery in older patients. r Majority of troponin rises were asymptomatic. r One-year mortality and cardiac events are significantly higher for patients with a troponin rise compared with those without. r Interventions are needed to improve outcome for these patients.
